Federal and Louisiana Laws and Regulations
Federal and Louisiana Laws and Regulations
This domain tests how federal and state layers interact: the Federal Food, Drug, and Cosmetic Act, the Controlled Substances Act, HIPAA, DSCSA, and the Louisiana Pharmacy Practice Act and Board rules.
Core rules
- Federal law sets minimum standards for drug approval, labeling, controlled substances, privacy, and supply-chain documentation. Louisiana law may be stricter but cannot authorize what federal law prohibits.
- The Louisiana Pharmacy Practice Act and LAC Title 46, Part LIII define licensure, dispensing, records, and discipline. Board rules are enforceable and are frequently more detailed than the statute.
- DSCSA requires transaction information and verification for prescription drug packages; suspect or illegitimate product must be quarantined and investigated.
- HIPAA permits treatment, payment, and operations disclosures but requires minimum necessary and safeguards; state law may add confidentiality protections.
- Inspections and investigations may involve the Board, DEA, and other agencies. Responses must be accurate and timely; never alter records after a request.
Worked example
A wholesaler delivers a case with missing transaction information. The receiving technician wants to shelve it because the product is needed. The pharmacist must quarantine the product, request complete DSCSA documentation, and not dispense until the chain is verified. The same principle applies to a recall: segregate, document, and notify.
Traps
Thinking state law overrides federal scheduling; treating HIPAA as the only privacy rule; accepting incomplete DSCSA data; confusing DEA registration with a Louisiana controlled-substance registration; answering an inspector with guesses or altered records.